<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39090638</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1753-2000</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Child and adolescent psychiatry and mental health</Title><ISOAbbreviation>Child Adolesc Psychiatry Ment Health</ISOAbbreviation></Journal><ArticleTitle>Antidepressant treatment initiation among children and adolescents with acute versus long COVID: a large retrospective cohort study.</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13034-024-00787-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Child and adolescent antidepressant use increased post-pandemic, but it is unknown if this disproportionally affected those who develop post-acute sequelae of coronavirus disease 2019 (COVID) or long COVID. This study compared the risk of antidepressant initiation among children and adolescents with long COVID with those who had COVID but did not have evidence of long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Our retrospective cohort study of children and adolescents aged 3-17 years at the first evidence of COVID or long COVID from October 1, 2021 through April 4, 2022 was conducted within Komodo's Healthcare Map<sup>&#x2122;</sup> database. The index date was the earliest date of a medical claim associated with a COVID (COVID comparators) or long COVID diagnosis (long COVID cases). The baseline period was six months before the index date. The outcome was antidepressant initiation within twelve months after the index date. Due to the large number of COVID relative to long COVID cases, COVID comparators were randomly selected with a ratio of 2 COVID to 1 long COVID. We used propensity score matching to control for confounding due to imbalances in the baseline covariates. Log-binomial models estimated the relative risk (RR) of antidepressant initiation in the propensity score matched sample. We conducted several sensitivity analyses to test the robustness of our findings to several assumptions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our child and adolescent sample included 18 274 with COVID and 9137 with long COVID. Compared with those with COVID, a larger proportion of long COVID children and adolescents had psychiatric disorders, psychotropic use, medical comorbidities, were previously hospitalized, or visited the emergency department. In the propensity score-adjusted analysis, the long COVID group had a statistically significant higher risk of antidepressant initiation relative to the COVID comparator (adjusted-RR: 1.40, 95% CI&#x2009;=&#x2009;1.20, 1.62). Our findings were robust across sensitivity analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The increased risk of antidepressant initiation following long COVID warrants further study to better understand the underlying reasons for this higher risk. Emerging evidence of long COVID's impact on child mental health has important implications for prevention and early interventions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Phuong Tm</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD, 21201, USA. phuong.tran@umaryland.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amill-Rosario</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD, 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>dosReis</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD, 21201, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Child Adolesc Psychiatry Ment Health</MedlineTA><NlmUniqueID>101297974</NlmUniqueID><ISSNLinking>1753-2000</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antidepressant medications</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Child and adolescent</Keyword><Keyword MajorTopicYN="N">Mental health</Keyword><Keyword MajorTopicYN="N">Mood</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Psychopharmacology</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>0</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39090638</ArticleId><ArticleId IdType="pmc">PMC11295664</ArticleId><ArticleId IdType="doi">10.1186/s13034-024-00787-z</ArticleId><ArticleId IdType="pii">10.1186/s13034-024-00787-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023. 10.1038/s41579-022-00846-2. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12:9950. 10.1038/s41598-022-13495-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;86. 10.1007/s15010-021-01666-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Disease J. 2021;40:e482&#x2013;7. 10.1097/INF.0000000000003328</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahratian A, Adjaye-Gbewonyo D, Lin JS, Saydah S. Long COVID in Children: United States 2022. NCHS Data Brief. 2023.&#xa0; https://www.cdc.gov/nchs/data/databriefs/db479.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">37756128</ArticleId></ArticleIdList></Reference><Reference><Citation>Re&#x2019;em Y, Stelson EA, Davis HE, McCorkell L, Wei H, Assaf G, et al. Factors associated with psychiatric outcomes and coping in Long COVID. Nat Mental Health. 2023;1:361&#x2013;72.10.1038/s44220-023-00064-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44220-023-00064-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;27. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID-19 symptoms at 6 months after onset and the role of Vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6:e2251360. 10.1001/jamanetworkopen.2022.51360</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>The White House. Memorandum on Addressing the Long-Term Effects of COVID-19. The White House. 2022.https://www.whitehouse.gov/briefing-room/presidential-actions/2022/04/05/memorandum-on-addressing-the-long-term-effects-of-covid-19/#:~:text=My%20Administration%20recognizes%20the%20toll,Term%20Effects%20of%20COVID%2D19. (accessed 9 Oct2023).</Citation></Reference><Reference><Citation>Bevilacqua L, Fox-Smith L, Lewins A, Jetha P, Sideri A, Barton G, et al. Impact of COVID-19 on the mental health of children and young people: an umbrella review. J Epidemiol Community Health. 2023;77:704&#x2013;9. 10.1136/jech-2022-220259</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2022-220259</ArticleId><ArticleId IdType="pubmed">37620009</ArticleId></ArticleIdList></Reference><Reference><Citation>Amill-Rosario A, Lee H, Zhang C, dosReis S. Psychotropic prescriptions during the COVID-19 pandemic among U.S. Children and Adolescents Receiving Mental Health Services. J Child Adolesc Psychopharmacol. 2022;32:408&#x2013;14. 10.1089/cap.2022.0037</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/cap.2022.0037</ArticleId><ArticleId IdType="pubmed">36067121</ArticleId></ArticleIdList></Reference><Reference><Citation>Benistand P, Vorilhon P, Laporte C, Bouillon-Minois J-B, Brousse G, Bagheri R, et al. Effect of the COVID-19 pandemic on the psychotropic drug consumption. Front Psychiatry. 2022;13:1020023. 10.3389/fpsyt.2022.1020023</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.1020023</ArticleId><ArticleId IdType="pmc">PMC9797694</ArticleId><ArticleId IdType="pubmed">36590615</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan S, Racine N, Vaillancourt T, Korczak DJ, Hewitt JMA, Pador P, et al. Changes in depression and anxiety among children and adolescents from before to during the COVID-19 pandemic: a systematic review and Meta-analysis. JAMA Pediatr. 2023;177:567. 10.1001/jamapediatrics.2023.0846</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2023.0846</ArticleId><ArticleId IdType="pmc">PMC10152379</ArticleId><ArticleId IdType="pubmed">37126337</ArticleId></ArticleIdList></Reference><Reference><Citation>Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a Meta-analysis. JAMA Pediatr. 2021;175:1142. 10.1001/jamapediatrics.2021.2482</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2482</ArticleId><ArticleId IdType="pmc">PMC8353576</ArticleId><ArticleId IdType="pubmed">34369987</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiger M, Wesselhoeft R, Karlsson P, Handal M, Bliddal M, Cesta CE, et al. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. J Affect Disord. 2023;323:292&#x2013;8. 10.1016/j.jad.2022.11.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.11.068</ArticleId><ArticleId IdType="pmc">PMC9691511</ArticleId><ArticleId IdType="pubmed">36442654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf K, Schmitz J. Scoping review: longitudinal effects of the COVID-19 pandemic on child and adolescent mental health. Eur Child Adolesc Psychiatry. 2023. 10.1007/s00787-023-02206-8. 10.1007/s00787-023-02206-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00787-023-02206-8</ArticleId><ArticleId IdType="pmc">PMC10119016</ArticleId><ArticleId IdType="pubmed">37081139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnet U, Juckel G. COVID-19 outcomes: does the use of psychotropic drugs make a difference? Accumulating evidence of a beneficial effect of Antidepressants&#x2014;A scoping review. J Clin Psychopharmacol. 2022;42:284&#x2013;92. 10.1097/JCP.0000000000001543</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000001543</ArticleId><ArticleId IdType="pmc">PMC9042214</ArticleId><ArticleId IdType="pubmed">35420565</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskotsky T, Mari&#x107; I, Tang A, Oskotsky B, Wong RJ, Aghaeepour N, et al. Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants. JAMA Netw Open. 2021;4:e2133090. 10.1001/jamanetworkopen.2021.33090</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.33090</ArticleId><ArticleId IdType="pmc">PMC8593759</ArticleId><ArticleId IdType="pubmed">34779847</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart TG, Rebolledo PA, Mourad A, Lindsell CJ, Boulware DR, McCarthy MW, et al. Higher-dose fluvoxamine and Time to sustained recovery in outpatients with COVID-19: the ACTIV-6 Randomized Clinical Trial. JAMA. 2023;330:2354. 10.1001/jama.2023.23363</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.23363</ArticleId><ArticleId IdType="pmc">PMC10656670</ArticleId><ArticleId IdType="pubmed">37976072</ArticleId></ArticleIdList></Reference><Reference><Citation>Komodo Health. Komodo Homepage. https://www.komodohealth.com/ (accessed 24 Oct2023).</Citation></Reference><Reference><Citation>McGrath LJ, Scott AM, Surinach A, Chambers R, Benigno M, Malhotra D. Use of the Postacute Sequelae of COVID-19 diagnosis code in routine clinical practice in the US. JAMA Netw Open. 2022;5:e2235089. 10.1001/jamanetworkopen.2022.35089</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.35089</ArticleId><ArticleId IdType="pmc">PMC9539719</ArticleId><ArticleId IdType="pubmed">36201207</ArticleId></ArticleIdList></Reference><Reference><Citation>Samji H, Wu J, Ladak A, Vossen C, Stewart E, Dove N, et al. Review: Mental health impacts of the COVID-19 pandemic on children and youth&#x2013;a systematic review. Child Adoles Ment Health. 2022;27:173&#x2013;89.10.1111/camh.12501</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/camh.12501</ArticleId><ArticleId IdType="pmc">PMC8653204</ArticleId><ArticleId IdType="pubmed">34455683</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothe J, Buse J, Uhlmann A, Bluschke A, Roessner V. Changes in emotions and worries during the Covid-19 pandemic: an online-survey with children and adults with and without mental health conditions. Child Adolesc Psychiatry Ment Health. 2021;15:11. 10.1186/s13034-021-00363-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13034-021-00363-9</ArticleId><ArticleId IdType="pmc">PMC7897360</ArticleId><ArticleId IdType="pubmed">33612122</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xfc;rmer T, Wyss R, Glynn RJ, Brookhart MA. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014;275:570&#x2013;80. 10.1111/joim.12197</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12197</ArticleId><ArticleId IdType="pmc">PMC4037382</ArticleId><ArticleId IdType="pubmed">24520806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushnell G, Sun JW, dosReis S, Camelo Castillo W, Czaja AS, Durrieu G, et al. Geographic trends in Pediatric psychotropic medication dispensing before and after the start of the COVID-19 pandemic. PS. 2023;74:880&#x2013;4.10.1176/appi.ps.20220314</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ps.20220314</ArticleId><ArticleId IdType="pmc">PMC10403367</ArticleId><ArticleId IdType="pubmed">36751905</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Stafford J, Moltrecht B, Huggins CF, Kwong ASF, Shaw RJ, et al. Psychological distress, depression, anxiety, and life satisfaction following COVID-19 infection: evidence from 11 UK longitudinal population studies. Lancet Psychiatry. 2022;9:894&#x2013;906. 10.1016/S2215-0366(22)00307-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00307-8</ArticleId><ArticleId IdType="pmc">PMC9560745</ArticleId><ArticleId IdType="pubmed">36244359</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Lee GM, Razzaghi H, Lorman V, Mejias A, Pajor NM, et al. Clinical features and Burden of Postacute Sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176:1000. 10.1001/jamapediatrics.2022.2800</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors Associated with Post&#x2013;&#x2009;COVID-19 Condition: a systematic review and Meta-analysis. JAMA Intern Med. 2023;183:566. 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennelly CE, Nguyen ATP, Sheikhan NY, Strudwick G, Ski CF, Thompson DR, et al. The lived experience of long COVID: a qualitative study of mental health, quality of life, and coping. PLoS ONE. 2023;18:e0292630. 10.1371/journal.pone.0292630</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0292630</ArticleId><ArticleId IdType="pmc">PMC10575511</ArticleId><ArticleId IdType="pubmed">37831706</ArticleId></ArticleIdList></Reference><Reference><Citation>Au L, Capotescu C, Eyal G, Finestone G. Long covid and medical gaslighting: dismissal, delayed diagnosis, and deferred treatment. SSM - Qualitative Res Health. 2022;2:100167.10.1016/j.ssmqr.2022.100167</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ssmqr.2022.100167</ArticleId><ArticleId IdType="pmc">PMC9448633</ArticleId><ArticleId IdType="pubmed">36092770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, Cox TO, Dohnalov&#xe1; L, Litichevskiy L, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;e486720. 10.1016/j.cell.2023.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz BA, Hoertel N, Lenze EJ, Jalali F, Reiersen AM. Association between antidepressant use and ED or hospital visits in outpatients with SARS-CoV-2. Transl Psychiatry. 2022;12:341. 10.1038/s41398-022-02109-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-02109-3</ArticleId><ArticleId IdType="pmc">PMC9395392</ArticleId><ArticleId IdType="pubmed">35995770</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, S&#xe1;nchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021;26:5199&#x2013;212. 10.1038/s41380-021-01021-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01021-4</ArticleId><ArticleId IdType="pubmed">33536545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Madlock-Brown C, Baratta JM, Bhatia A, Davis H, Girvin A, et al. Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med. 2023;21:58. 10.1186/s12916-023-02737-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, et al. Long COVID through a Public Health Lens: an Umbrella Review. Public Health Rev. 2022;43:1604501. 10.3389/phrs.2022.1604501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Health and Human Services. Guidance on Long COVID as a Disability Under the ADA, Sect.&#xa0;504, and Sect.&#xa0;1557. Civil Rights. 2021.&#xa0;https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disability/index.html#:~:text=2.,or%20more%20major%20life%20activities. (accessed 19 Feb2014).</Citation></Reference><Reference><Citation>National Institutes of Health. NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million. The NIH Director. 2024.&#xa0;https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-bolster-recover-long-covid-research-efforts-through-infusion-515-million (accessed 29 Feb2024).</Citation></Reference><Reference><Citation>Larsen L, Schauber SK, Holt T, Helland MS. Longitudinal Covid-19 effects on child mental health: vulnerability and age dependent trajectories. Child Adolesc Psychiatry Ment Health. 2023;17:104. 10.1186/s13034-023-00652-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13034-023-00652-5</ArticleId><ArticleId IdType="pmc">PMC10476387</ArticleId><ArticleId IdType="pubmed">37667287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>